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ABSTRACT Two variants in immunoglobulin heavy chain production, derived from the
MPC 11 mouse myeloma cell line, make short heavy (H) chains with identical precise deletions
of the CH3 domain . The CH 3 domain is expressed in the H chain mRNA from both variants.
Although in vitro translation of this mRNA produces one H chain species, deleted heavy
chains are secreted as heavy-light (HL) and HZLZ moieties in contrast to MPC 11, which
secretes only HZLZ. The heavy chains of HL apparently contain more carbohydrate (CHO+)
than do the H chains of HZ LZ, and inhibition of N-linked glycosylation results in the secretion
of relatively more HZLZ. Here we present evidence suggesting that (a) the absence of the CH3
domain has led to conformational changes in these molecules, (b) these changes permit
posttranslational glycosylation, and (c) unrestrained glycosylation can frequently yield unusual
CHO' structures that make complete assembly unlikely.
The mouse myeloma cell line, MPC 11, has been the source
ofmany variants affecting immunoglobulin heavy (H)' chain
production. One such variant, M 311, synthesizes a short H
chain of 40,000 mol wt as compared with the parental
MPC 11 y2b H chain of55,000 mol wt (1, 2). We have shown
by primary structural analysis that the smaller sized Ig H
chain is due to precise deletion of the CEi3 domain (3).
Comparison of the amino acid sequence obtained from the
COOH-terminal peptide of M 311 and the DNA sequence of
the y2b constant region gene suggested that deletion of two
adenines from a stretch of five produced a nonsense codon
and a consequentpremature termination ofH chain synthesis
(3). The lesion in the H chain was accompanied by other
phenotypic alterations affecting its glycosylation and assem-
bly. For example, a significant amount of cytoplasmic M 311
H chain was shown to be nonglycosylated in contrast to
parental H chains, all of which bear carbohydrate (4). In
addition, M 311 secretes both HZLZ (L, light) and HL species
while the parent cell line secretes only the fully assembled
molecule (4).
'Abbreviations used in this paper:
￿
H, heavy (chain); L, light (chain);
mRNA, messenger RNA; Tm, tunicamycin.
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Another variant, independently derived from MPC 11,
ICR 4.68 .13.9 (13.9), also synthesizes a short (40,000 mol wt)
H chain and large amounts of HL (2). Here we report that
both M 311 and 13.9 synthesize a single H chain with appar-
ently identical COOH-terminal deletions. The relationship
between alterations in assembly and glycosylation patterns is
explored.
MATERIALS AND METHODS
Purification of Immunoglobulin Paraprotein and Isolation
of CNBr fragments:
￿
Immunoglobulins M 311 and 13.9 were purified as
described (5). Hz1n and HL were separated on a column ofUltrogel AcA 44
(LKB Instruments, Washington, DC), equilibrated in 0.15 M NH4HC03 (3).
Both M 311 and 13.9 HZLZ and HL were submitted to CNBr cleavage in 70%
formic acid (5). The cleavage products, pools I' and II', were separated as
described (5). Separation of CNBr fragments from pool I' and pool II' was
carved out as described (5, 6).
Amino Acid Analysis:
￿
Peptides were hydrolyzed in 0.5 ml 6 N HCl
and 15 u1 1 M phenol at 100°C for 20 h under vacuum (20 gm). Homoserine
lactone was decyclized as described (7). Samples were then analyzed on a
Durrum D-500 amino acid analyzer.
SDS PAGE:
￿
5% SDS PAGE was performed as described (8). 10-20%
SDS polyacrylamide Tris-Cl gradient gels were prepared according to the
method of Maizel (9).
2215Cell Culture and Biosynthetic Labeling of Myeloma
Cells:
￿
Myeloma cells were grown as suspension cultures in Dulbecco's
modified Eagle's medium (Gibco Laboratories, Grand Island, NY), supple-
mented with 20% horse serum, nonessentialamino acids,glutamine, penicillin,
and streptomycin.
To biosynthetically label, we washed cellsand resuspended them to 3 x 106/
ml in Dulbecco's modified Eagle's medium without Na-pyruvate and all other
amino acids (Gibco Laboratories, formula No. 78-0632), and supplemented
with 10% fetal calfserum and 25 ruCi of "C-amino acids (valine, threonine,
and leucine [New England Nuclear, Boston, MAJ).
Inhibition of Glycosylation: Inhibition of glycosylation was
achieved by radiolabeling asdescribed above except that cells were treated with
2 rug/ml oftunicamycin (Tm) (I mg/ml in DMSO) for 1-2 h at 37°C before
labeled amino acids were added (10). Control wells received the same volume
of DMSO without Tin. Tin was a gift from Dr. R. Hamill, Eli Lilly, Indianap-
olis.
Immunoprecipitation (11): Staphylococcus aureus (IgSorb; En-
zyme Center, Boston, MA) was washed and stored as a 10% suspension (wt/
vol) at -70°C. I ml of labeled myeloma secretions was treated with 5 ref of
rabbit anti-mouse IgG2 antisera on ice for 1 h. 50 rd of washed S. aureus was
added and kept on ice for 30 min and the immune precipitate was collected by
centrifugation. The resulting pellet was washed threetimes in S. aureus washing
buffer minus ovalbumin. The washed precipitate was resuspended in 20-25 Al
of2% SDS (Bio-Rad Laboratories, Richmond, CA) and boiled for 2 min.
RNA Isolation and Analysis:
￿
Total cytoplasmic RNA wasprepared
essentially according to the guanidinium hydrochloride method (12). To pre-
pare RNA for in vitro translation, we found that a phenol/chloroform extrac-
tion followed by an ether extraction was necessary. Poly A containing RNA
was isolated by affinity chromatography on an oligo dT cellose column (13).
RNA was sized in an electrophoretic denaturing system using formamide/
formaldehyde. Gels were 1.0% agarose in a buffer containing 10 mM 3-(N-
Morpholino)propane-sulphonic acid (MOPS) (Leonard Garfinkel, personal
communication), 5 mM Na-acetate, pH 7.0, l mM EDTA, and 2.2 M form-
aldehyde (Fisher Scientific Co., Pittsburgh, PA; 37% wt/wt). Running buffer
was 10 mM MOPS, 5 mM Na-acetate, pH 7.0, 1 mM EDTA. Samples were
prepared in a solution of 1x running buffer, 2.2 M formaldehyde, and 50%
formamide (MC&B Mfg. Chemists, Inc., Norwood, OH). Up to 7 rag oftotal
cytoplasmic RNA or 2 lug of polyA' RNA was loaded per gel track and
electrophoresed at 7 V/cm for 3 h. RNA was transferred from the agarose gel
toa nitrocellulose filter (14).
Probes were nick-translated to a specific activity of 108 cpm/Ag (15). When
restriction fragments were used as the probes, DNase was withheld from the
reaction mixture (15) and a specific activity of 107 cpm/lag was obtained.
Preparation of CH3 DNA Fragment from y2b:
￿
The plasmid
containing the complementary, DNA for the 721, gene, py2b (11)1 (16) was
digested with Sac I which generates a fragment of300 base pairscontaining the
C3 domain. The digest was electrophoresed in a Tris-borate polyacrylamide
gel, and the fragment containing the C713 domain wasisolated byelectroclution
(t7).
Probe for the Variable Region of the MPC 11 H Chain
Gene:
￿
A gift of Dr. Kenneth Marcu, State University of New York Stony
Brook, this was a 2.1 kilobase pair Hind III fragment of RBL216, a lambda
vector containing the MPC l l expressed y2b gene (18). The Hind III fragment
was inserted into the Hind III site ofpBR322.
RNA Hybridization:
￿
Filters were prehybridized in0.90 M NaCl, 0.90
M Na-citrate (3x standard saline-citrate buffer, SSC), 0.02% polyvinylpyrroli-
done, 0.02% BSA, 0.02% Ficoll, 0.1% SDS, 20 rug/ml polyadenylic acid, 50
rug/ml sheared salmon sperm DNA, 50% formamide at 42°C for 4 h. Hybridi-
zation was carved out in a fresh change of the above buffer with the addition
of 105 cpm per track ofRNA and 10% (wt/vol) ofdextran sulfate in a volume
of 1 ml per track for a minimum of8 h at 42°C. The nitrocellulose filters were
then put through fourconsecutive washes of0.1 x SSC and 0.1% SDS. Washes
were done at 50°C for 15 min each. Filters were prepared for rehybridization
by rinsing four times in boiling 0.01x SSC-0.01% SDS. Autoradiography was
done at -70°C using a DuPont Lightening-Plus intensifying screen (E. I.
DuPont de Nemours & Co., Inc., Newtown, CT).
In Vitro Translation:
￿
The wheat germ cell-free protein synthesizing
system was used as previously described (19). Dog pancreatic microsomal
membranes, prepared as described (20), were added to the cell-free system at a
final concentration of2 A,./ml.
RESULTS
Comparison by SDS PAGE of the H chains secreted from
13 .9 to those secreted by M 311 showed that both short H
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chains are heterogeneous, co-migrating at an average molec-
ular weight of 40,000, as compared with the 55,000 M, H
chain produced by the parental cell line, MPC 11 (2). The
simplest way to account for the decreased molecular weight
in 13.9 is by a C-terminal deletion like that found in M 311 .
When CNBr fragmentswere generated from 13.9 Ig molecules
and subjected to gel filtration, the elution profile was altered
from that of MPC 11 but similar to that obtained from
M 311 (3). Like M 311, 13.9 lacked the C-terminal parental
fragments, II. 1 and 11.3 (Fig. 1), derived from the C-terminal
segment of the CH2 domain and the entire CH3 domain.
Instead, 13 .9 had a new fragment (II.C) that contained no
homoserine (Fig. 1 and Table I). Cyanogen bromide digestion
cleaves methionine residues to produce a homoserine lactone
at the new C-terminal position in each resulting peptide. The
only fragment lacking homoserine is the C001-1-terminal
fragment of the intact H chain. The absence of homoserine
from the amino acid composition of CNBr fragment ILC
indicated ILC to be the C001-1-terminal fragment in 13 .9 H
chains. The amino acid composition of this fragment was
identical to that of II.C from M 311 (Table I). We therefore
infer that the amino acid sequence of the C001-1-terminal
segment of 13.9 is identical to that obtained for CNBr frag-
ment II.C from M 311 HL molecules. Thus 13.9, like M 311,
has a precise C3 domain deletion that could result from a
deletion oftwo adenine bases leading to immediate premature
termination (Fig. 1 B). To substantiate this hypothesis, we







































Carboxyl-terminal deletion in M 311 and 13.9 H chains.
(A) Schematic of CNBr fragments of H chains of MPC 11, M 311,
and 13.9. The arrow marks the separation by CNBr cleavage of N-
terminal Pool I fragments (1.5, 1.3, and 1 .4, coupled to a large
segmentof L chain) from C-terminal Pool II fragments (11.2, 11.1,and
11.3, for MPC 11 ; 11 .2 and II.C for M 311 and 13.9). CNBr fragments
within Pool I and Pool II remain linked by disulfide bridges. (B)
Comparison of the sequence of CNBr fragment 11 .1 from MPC 11
and II.C from M 311 HL. The amino acid composition of II.C from
13.9 is identical to that of II.C from M 311 and thus the sequences
are presumed to be identical. The nucleotide sequence for
MPC 11 is that reported forthe y2b DNAsequence (25). Adeletion
of two adenine bases would account for the observed substitution
of asparagine for lysine and immediate premature termination of
M 311 and 13 .9 H chains.Analysis ofmRNA from Variant Cells
To show that the 72W-CH3 domain sequences were expressed
in the RNA from these variant cell lines, we hybridized poly
A+ RNA with py2b (11)'-CH3, a probe that contained only the
CH3 domain (see Material and Methods) . This probe was
specific for the y2b gene, hybridizing relatively poorly with
,y2a genes . The probe hybridized to messenger RNA from
variant cells, (1 .2 kilobase pairs, 17.5S; in agreement with the
published size of MPC 11 H chain mRNA [ 16]) (Fig . 2) .
Although equal quantities of mRNA were applied to each
track, M 311 RNA had a relatively less intense signal than
that of the other mRNAs. When the same nitrocellulose filter
was erased and rehybridized with a restriction fragment con-
taining the MPC 11 variable region sequence, M311 mRNA
showed a similar reduction in signal (Fig . 2B). Thus, intact
heavy chain specific mRNA was present in smaller quantities
in the M 311 preparation . We conclude that the y2b-CH3
TABLE I
Amino Acid Compositions of Fragment ILC from 13.9 and
M311
" Fragment I LC was isolated from H2L2.




main is expressed in
variant H chain mRNA .
Poly A* RNA was iso-
lated from MPC 11,




on 1 .0% agarose gels in
a 10 mM MOPS buffer
system (Material and
Methods) . 2 tag of poly
A* RNA was loaded per
track . RNA was trans-
ferred to nitrocellulose
and (A) hybridized with
the -y2b-CH3 restriction
fragment probe, or (B)
filter A was washed to remove y2b-CH3-labeled probe and rehy-
bridized with the Vnnrc 11 restriction fragment probe . Size markers
were 28S and 18S eucaryotic and 23S and 16S bacterial ribosomal
RNA (not shown) .
domain is expressed in the mRNA of both M 311 and 13.9,
consistent with the hypothesis that these variants arose by a
frameshift mutation .
In Vitro Translation of Variant mRNA
M 311 and 13.9 secrete approximately equal amounts of
HL and H 2L 2 , in contrast to the parental cell line MPC 11,
which secretes predominantly H2L2 . To examine whether the
heavy chains associated with HL and H2L2 represented genet-
ically distinct H chains, we isolated total cytoplasmic RNA
from variant cell lines and then translated it in the wheat
germ system . The immunoprecipitated translation products
were analyzed by gel electrophoresis (Fig. 3, data are shown
for 13 .9) . The finding of a single heavy chain band implies
that a single primary translation product is responsible for
both HL and H2L2 forms of Ig produced by 13.9 andM 311 .
Unusual Glycosylation Perturbs Assembly
An alternative explanation to account for the substantial
amounts of dimeric HL secreted from the variant cell lines is
that a posttranslational event, such as glycosylation, alters the
H chain structure, thus inhibiting it from completely assem-
bling into H2L2 . Treatment of cell cultures with Tm will
inhibit asparagine-linked carbohydrate addition while not
significantly affecting Ig secretion (21), making it possible to
test this hypothesis . The amount of secreted H2L2 relative to
HL is greaterwhen produced in the presence ofTm than that
seen in the absence of Tm (Fig . 4) . Though MPC 11 was
slightly affected by Tm treatment, the perturbation was not
as visible since 90-95% of its H chain is normally assembled
into H 2L 2 . This result suggests that the presence of an N-
linked glycosylation product in M 311 and 13.9 diminishes
the relative amount of secreted H2L2 . Furthermore, previous
studies (22) have shown that this shift does not result from
intracytoplasmic degradation of nonglycosylated heavy chain .
H Chains of Secreted HL and H2L2 Are
Differentially Glycosylated
To directly ascertain whether the H chains associated with
FIGURE 3 A single primary translation product is
responsible for M 311 and 13.9 H chains . Total
cytoplasmic RNA from 13 .9 was translated in a
wheat germ extract system, immunoprecipitated,
and analyzed by 10-20% SIDS PAGE (Material and
Methods) .
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Amino acid 13 .9* M311 ;
CMCys 0.84 1
Asp 4.1 4
Thr 1 .0 1
Ser 2.2 3
Hser - -
Glu 2 .1 2
Pro 1 .9 2
Gly 1 .1 1
Ala - -
Val 1 .1 1
Ile 1 .7 2
Leu 0.90 1
Tyr - -
Phe 1 .0 1
His - -
Lys 3 .8 4
Arg 1 .0 1HL and H 2L2 could be distinguished, radiolabeled HL and
H2L2 secreted from M 311 and 13.9 were isolated by gel
filtration chromatography (Material and Methods) .When the
mobilities ofthe H chains were compared by gel electropho-
resis, the H chains of HL and H2L 2 both showed multiple
bands (Fig. 5). The predominant band for H ofH2L2 had the
lower apparent molecular weight implying that additional
carbohydrate could account for theH chains ofHL, consistent
with the results ofTm treatment described above . Since there
is only a single primary translation H chain product made by
M 311 and 13.9 mRNA, this result supports the notion that
differential glycosylation may influence Ig assembly in these
variant cells.
Comparison ofCytoplasmic and Secreted H
Chains
It had been previously demonstrated that in vivo most of
theM 311 H chain remained nonglycosylated during the first
few minutes after translation, but with time, the cytoplasmic
H chain pool became increasingly glycosylated (4) . The same
phenomenon is seen in 13.9 cells. After these cells were
biosynthetically labeled for 10 h, analysis ofthe immunopre-
cipitated cytoplasmic H chain by gel electrophoresis showed
FIGURE 5
￿
The H chains of HL and 1- 121_2 are
differentially glycosylated . M311 cells were
biosynthetically labeled, and HL and H 2L2
were separated by gel filtration chromatog-
raphy as described in Material and Meth-
ods . The isolated Ig variant molecules were
reduced and electrophoresed on a 10-20%
polyacrylamide gradient gel in the presence
of SDS (Material and Methods). The gel was









assembly of short H
chains . MPC 11, M 311,
and 13.9 cells were la-
beled for 10 h with '°C
Val, Thr, and Leu . Se-
creted Igs were immu-
noprecipitated and ex-
amined by SIDS PAGE
(5%) . + and - indicate
the presence or ab-
sence of Tm in the la-
beling cultures .
presence of Tm ; (lane 3) cytoplasmic, in
5) secreted, in the presence of Tm ; and
absence ofTm .
FIGURE 6 Comparison
of cytoplasmic and se-
creted variant H chains
analyzed by 10-20%
gradient SIDS PAGE . To-
tal cytoplasmic RNA
from 13.9 was trans-
lated in a wheat germ
extract system in the
absence (lane 1) and
presence (lane 4) of
dog pancreatic mem-
branes . Biosynthetically
labeled (10 h) and im-
munoprecipitated Ig
produced by 13 .9 ; (lane
2) cytoplasmic, in the
the absence ofTm ; (lane
(lane 6) secreted, in the
two H chain bands in a ratio of about 90/10 (upper to lower
bands) (Fig . 6, lane 3) . Similar analyses of shorter periods of
labeling-15 and 30 min and 3 h-show progressive move-
ment of H chain from the lower to upper bands (data not
shown) . To show that this molecular weight change is due to
glycosylation, we biosynthetically labeled 13.9 cells in the
presence of Tm and analyzed them by gel electrophoresis.
Cytoplasmic H chains from cells treated with Tm migrate as
a single band coincident with the lower cytoplasmic H chain
band observed in untreated cells (Fig. 6, lanes 2 and 3). Our
studies here indicate that after 10 h of biosynthetic labeling,
the predominant cytoplasmic H chain form in 13 .9, like
M 311, is glycosylated . The glycosylated cytoplasmicH chain
has a mobility identical to that ofH chain synthesized by in
vitro translation in the presence of microsomal membranes
(Fig. 6, lane 4) .
Additional glycosylation events occur upon secretion . Se-
creted H chains from M 311 and 13.9 gave a heterogeneous
pattern of three to four bands when analyzed by gel electro-
phoresis (Fig . 6, lane 6). Treatment of MPC 11 with Tm
yielded one secreted H chain band of faster mobility (data
not shown) . In contrast, M 311 and 13.9 expressed two
secreted H chain bands after Tm treatment, (Fig . 6, lane 5) .
The lower of these two H chain bands is likely to represent
the completely nongycosylated H chain form because it co-
migrates with cytoplasmicH chain immunoprecipitated from
cells that had been radiolabeled in the presence ofTm (Fig .
6, compare lanes 2 and 5). By inference, the upperband likely
contains O-linked sugar moieties, which are known to be
unaffected by Tm treatment (23, 24) . These results suggest
that late steps of glycosylation, including presumptive 0-
linked sugars, occur late in the secretory pathway . It remains
unclear whether the secreted H chain is drawn specifically
from either or both CHO' or CHO- cytoplasmic H chain
pools .
Comparison of Glycosylation Sites on the H
Chains ofMPC 11, M 311, and 13 .9
Observation of multiple bands for secreted Ig H chain from
13.9 andM 311 suggests the existence of multiple glycosyla-
tion sites. The amino acid sequence constellation of Asn-X-
Ser/Thr has been shown to be a requirement for addition of
asparagine-linked carbohydrate (24). One asparagine-linked
glycosylation site for MPC 11 H chain was predicted fromthe complete DNA sequence (25) and confirmed by subse-
quent studies (26, 27). It lies in the C-terminal region of the
molecule, in the peptide corresponding to CNBr fragment 11.2
(Fig. l A) . To confirm the presence of this glycosylation site
in the variants, we isolated fragment 11.2 from M 311 H2L2
and submitted it to tryptic digestion . The resulting tryptic
peptides were separated by gel filtration and the pools were
submitted to amino acid analysis. A tryptic peptide was
identified with the amino acid molar ratios ofGlu, Asp2, Tyr,
Ser, Leu, Arg, which corresponded to the predicted glycosyl-
ated peptide . The sugar composition (derived by Dr . J . Hak-
imi, Albert Einstein College of Medicine, using gas chroma-
tography) was fucose 1 .15, mannose 3.0, galactose 1 .68, and
G1cNAc 3.74, where mannose was used to normalize the
ratios), and was as expected for complex type N-linked sugars
(24) . It can be concluded that like MPC 11, the M 311 H
chain contains an N-linked sugar in the CH2 domain.
Other glycosylation sites forMPC 11 and the short H chain
variants were reported to be associated with the N-terminal
portion of the molecule-most likely within CNBr fragment
1.32 (Fig . 1 ; see references 26, 27). Cyanogen bromide diges-
tion ofthe MPC 11 Ig molecule generates two major peptide
fragments, Pool I (which contains fragment 1.3) and Pool II
(which contains fragment 11.2), approximately equivalent to
Fab and Fc, respectively (Fig. 1, reference 9) . When the CNBr
fragments associated with Pool I of parental and variant H
chains were compared by amino acid analysis, no differences
were found (28) . Therefore, any differences in migration of
Pool I fragments ofMPC 11, M 311, and 13.9 should reflect
differences in carbohydrate . In Fig. 7, two major bands are
seen for Pool I from bothMPC 11 andM 311 H ZL Z ; however,
while the lower bands co-migrate, the upper ones do not .
After treatment with Tm, no apparent change in Pool I bands
is seen (Fig. 7) . The results obtained for 13.9 Pool "I" were
identical to those found forM 311 . These data suggest that
there are glycosylation sites in the Fab portion of these Igs
not predicted from the DNA sequence of the gene coding for
the MPC 11 H chain . In addition, the sugar moiety present
in at least one site in this segment of MPC 11 differs from
that seen forM 311 or 13.9 .
DISCUSSION
M 311 and 13.9 are two variant cell lines independently
isolated from MPC 11, both ofwhich produce short H chains
of 40,000 mol wt . When compared with the parental y2b
heavy chain, both variant H chains were found to have
comparable C-terminal deletions comprising the CH3 domain.
The C-terminal CNBr fragment of M 311 is identical in
primary sequence to a corresponding segment of a parental
H chain CNBr fragment with the exception of a lysine to
asparagine substitution at the C-terminal residue (3). The
amino acid composition of the corresponding C-terminal
peptide in 13.9 is identical with that obtained forM 311 and
suggests that the same genetic mechanism generated these
variants: a -2 frameshift mutation, producing a nonsense
codon that leads to premature termination (3) . Northern blot
hybridization showed that -y2b-CH3 sequences are expressed
in the short variants, supporting this hypothesis.
2 Using the gel filtration protocol outlined by us in previous studies,
Weitzman and Portmore showed radiolabel to be associated with
Pool 1 .3 in Fig. 3, reference 27 . However, Pool 1 .3 was improperly
named Pool 1 .4 in their manuscript.
FIGuRF 7 Glycosylation sites in
the Fab portion of MPC 11 and
M 311 . Cells were biosyntheti-
cally labeled and secretions were
immunoprecipitated (as in Mate-
rials and Methods), released from
5. aureus by addition of 70%
formic acid, digested with CNBr
as described to generate Pools I
and II, and separated by electro-
phoresis on S% SDS-PAGE under
nonreducing conditions . + and -
indicate treatment of the cultures
with Tm during the labeling pro-
cedure .
The deletion of the CH3 domain is accompanied by addi-
tional alterations in heavy chain glycosylation and assembly .
For example,M 311 assembles and secretes an unusually large
amount of dimeric HL as compared with the MPC 11 cell
line (4) . This observation has now been extended to 13.9, a
secondary variant cell line which expresses aH chain with the
same apparent genetic mutation as found in the M 311 H
chain. In contrast, Laskov et al. (29) have shown that mye-
loma cells producing normal-sized H and L chains do not
accumulate significant amounts of HL in the cytoplasm or
secretions.
We considered two possible explanations for the presence
of excess HL in variants making short H chains: (a) primary
structural differences between the H chains ofHL and HzLZ ,
or (b) an assembly blockage due to unusual glycosylation .
The first hypothesis was tested by in vitro translation of the
RNA isolated from the variants which showed that a single
H chain is produced . Accumulation ofHL in these variants,
therefore, does not reflect production of a second genetically
distinct H chain .
Rather, the assembly process appears to be perturbed by
two factors acting in synergy ; the absence of the CH3 domain
and aberrant glycosylation . It is quite possible that the differ-
ences in sugar moieties between MPC 11 and M 311 (and
presumably 13.9) have been initiated by the loss of the CH3
domain, which in turn confers conformational changes
throughoutthe molecule . In support ofthis, it has been shown
that alteration of protein conformation can lead to changes
in glycosylation pattern both for site attachment and subse-
quent sugar processing (22, 24, 28, 29) . Indeed, previous
studies have shown that in MPC 11 cells, H chains that have
completed translation can no longer be glycosylated while
both nascent and completedM 311 (and 13.9) H chains can
be glycosylated (4, 22, 30, 31) . It has also been shown that
the assembly ofM 311 H chain into a completeH2L2 molecule
proceeds more slowly than that ofMPC 11 (4) . X-ray diffrac-
tion studies ofthe IgG molecule indicate that theCHI and CL
domains interact as do the CH3 domains by noncovalent
forces . The CH2 domains, however, do not interact: the site
through which the CH2 domains would interact is obstructed
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chain that is progressively glycosylated will finally attain a
CHO+ structure that is too large to be accommodated be-
tween the two H chains and that will disrupt the orderly
progression of interchain disulfide bond formation. These H
chains will ultimately appear as HL halfmolecules. Consistent
with this suggestion is the finding that H chains isolated from
HL molecules carry higher MW sugar structures.
Analysis of secreted heavy chains produced by both M 311
and 13.9 variant cell lines showed multiple bands indicating
extensive glycosylation heterogeneity (Figs. 5 and 6). Inhibi-
tion of N-linked glycosylation with Tm reduced the number
of secreted H chains to two, rather than one as seen for
cytoplasmic H chains (Fig. 6). This suggests that a subpopu-
lation of secreted H chains may contain carbohydrates that
are unaffected by Tm treatment (e.g., O-linked sugars). Since
Tin treatment resulted in H chains that migrated more rap-
idly, these studies support the conclusion that almost all
secreted variant H chains are glycosylated. This differs from
an earlier study which reported that 30% of H chains secreted
by M 311 remain nonglycosylated (4). In that previous study,
conclusions based on data for cytoplasmic H chains were
assumed to apply to secreted H chains. Additionally, small
molecular weight differences contributed by carbohydrate
could not be discriminated with the gel electrophoresis system
used.
Weitzman et al. (26) have shown that there are two sugar
attachment sites in the MPC 11 H chain, one located in the
CE12 domain (fragment 11.2) and one in the N-terminal seg-
ment (fragment 1.3) (Fig. 2) (27). Only the former is predicted
from the DNA sequence to contain a site for N-linked sugar
(25). In M 311, three sugar moieties were found, two ofwhich
were presumed to be located at sites homologous to those
found in MPC 11, i.e., fragments 11.2 and 1.3 (26, 27). We
have confirmed the presence of sugar on the M 31111.2 CNBr
fragment: amino acid analysis and sugar composition of the
CHO' tryptic peptide have identified this sugar attachment
site as the asparagine-linked type. On the basis of differences
in mobility on P6 gel chromatography after pronase treat-
ment, Weitzman and co-workers (26, 27) had concluded that
none of the CHO' moieties present on M 311 was identical
to the MPC 11 parental forms. Neuraminidase treatment of
the carbohydrate moieties associated with the M 311 H chain
suggested that sialic acid is not responsible for CHO' hetero-
geneity (26). Comparison of the sugar structures in the H
chains of MPC 11 and M 311 was carried out by digestion
with endo-N-acetylglucosaminidase-D (26). The MPC 11 H
chain carried a minor large glycopeptide resistant to digestion
and a major smaller structure sensitive to digestion. In con-
trast, the M 311 H chain carried a relatively large endoglycos-
idase-resistant glycopeptide as the predominant species. Our
studies of MPC 11, M 311, and 13.9 show that the N-terminal
segment of the molecule, generated by CNBr cleavage (Pool
I, see Fig. 1), has two bands when analyzed by SDS PAGE,
reflecting the presence of differentially glycosylated forms
(Fig. 7). This pattern is unchanged after treatment of cells
with Tm, suggesting that an O-linked sugar resides in the N-
terminal of the parental chain. Taken together, these analyses
imply that the variant H chains have one N-linked sugar in
the 11.2 CNBr fragment and two other sugar moieties associ-
ated with the Fd region. (L chains are not glycosylated.)
Precedent for differential glycosylation is shown by human
H chains (34). In this case, membrane and secreted 6-type
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immunoglobulins are found as two primary translation prod-
ucts which are subsequently glycosylated to give four discrete
forms. McCune et al. (34) have suggested that this phenome-
non may reflect structural features of the H chains that are
incompatible with uniform attachment of core oligosaccha-
rides. A similar example of differential glycosylation is the
bovine pancreatic RNaes, A and B: although of presumptive
identical amino acid sequences, RNase B is glycosylated and
RNase A is not (35, 36).
Interestingly, the original MPC 11 tumor secreted large
amounts of HL dimer (37) while the MPC 11 myeloma cells
adapted to culture did not (38). The unusual glycosylation
pattern expressed in the variant cellsmay represent a reversion
to the original tumor phenotype. This explanation is sup-
ported by the observation that differential glycosylation occurs
only in the secreted Ig. The variant cell lines characterized
here will be good models for investigation of the subcellular
localization and post-translation modification of Ig protein
during secretion.
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